X-spine Systems has announced the market launch of its US Food and Drug Administration-cleared, Irix-A lumbar integrated fusion system.
Incorporating “state of the art” biomaterials and manufacturing processes, Irix-A combines a polymer body with an integrated titanium ring for added strength and durability, a titanium plasma coating of bone-apposing surfaces and a resilient locking mechanism for screw fixation, according to an X-spine press release. Irix-A is implanted in an anterior approach at one or two contiguous levels of the lumbosacral spine (L2-S1 inclusive).
Irix-A is the second addition to the Irix integrated interbody device family following the Irix-C cervical integrated fusion system. The integrated titanium ring in the Irix systems has been tested as providing twice the torsional strength of standard PEEK implants.
“Irix-A strengthens the standalone interbody market through proprietary technology,” states David Kirschman, president and chief executive officer of X-spine. “X-spine first launched titanium plasma coated implants in 2011, and will continue to expand product offerings with these technologies. The titanium plasma coating serves to improve resistance to device expulsion.”
X-spine will be exhibiting Irix-A along with its complete line of spinal devices and biologics at the American Academy of Orthopaedic Surgeons meeting (24–28 March, Las Vegas, USA).